Pulmonary Langerhans Cell Histiocytosis Clinical Trial
Official title:
Evaluation of Outcome of Adult Pulmonary Langerhans Cell Histiocytosis Based on Lung HRCT and Lung Function. A Multicenter Retrospective Study
this is a multicenter retrospective study on patients with pulmonary LCH who were sequentially evaluated by concomitant lung HRCT and lung function testing. The objectives of this study were: 1) to determine the changes over time of lung function parameters in patients with pulmonary LCH; 2) to compare the variations of HRCT and lung function results during follow-up; 3) to address the respective interest of these investigations for identifying the patients who eventually will experience a progression of their disease.
Pulmonary Langerhans cell histiocytosis (pulmonary LCH) is an uncommon disorder,
characterized by the accumulation of CD1a+ Langerhans cells (LCs) organized in granulomas
that develop in, and destroy the wall of distal bronchioles. In adults the disease occurs
predominantly in young smokers from both genders, with a peak incidence at 20-40 yrs of age,
although female may be slightly older. High resolution computed tomography (HRCT) of the
lung has provided a considerable input for the diagnosis of pulmonary LCH.
We conducted a multicenter retrospective study on patients with pulmonary LCH who were
sequentially evaluated by concomitant lung HRCT and lung function testing. The objectives of
this study were: 1) to determine the changes over time of lung function parameters in
patients with pulmonary LCH; 2) to compare the variations of HRCT and lung function results
during follow-up; 3) to address the respective interest of these investigations for
identifying the patients who eventually will experience a progression of their disease.
Results of this study may help to improve the management of patients with adult pulmonary
LCH.
;
Observational Model: Case-Only, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05114304 -
Prevalence of Mood and Anxiety Disorders in Adult Patients With Pulmonary Langerhans Cell Histiocytosis
|
||
Completed |
NCT03052101 -
Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell Histiocytosis
|